CLASS ACTION UPDATE for AMGN, UNFI and GWGHQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / April 12, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

AMGN Shareholders Click Here: https://zlk.com/pslra-1/amgen-class-action-loss-submission-form?prid=38264&wire=1
UNFI Shareholders Click Here: https://zlk.com/pslra-1/united-natural-foods-inc-lawsuit-submission-form?prid=38264&wire=1
GWGHQ Shareholders Click Here: https://zlk.com/pslra-1/gwg-holdings-inc-information-request-form-2?prid=38264&wire=1

* ADDITIONAL INFORMATION BELOW *

Amgen Inc. (NASDAQ:AMGN)

This lawsuit is on behalf of all persons who purchased or otherwise acquired Amgen common stock between July 29, 2020 and April 27, 2022, inclusive.
Lead Plaintiff Deadline : May 12, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/amgen-class-action-loss-submission-form?prid=38264&wire=1

According to the filed complaint, (a) the U.S. government claimed Amgen owed more than $3 billion in back taxes for tax years 2010, 2011, and 2012; (b) the U.S. government claimed Amgen owed more than $5 billion in back taxes for tax years 2013, 2014, and 2015; (c) the U.S. government would likely claim Amgen owed materially more to the U.S. government than investors had been led to believe for subsequent tax years for which the Company had used the same profit allocation treatment between its U.S. and Puerto Rico operations; (d) Amgen had not taken sufficient accruals to account for its outstanding tax liabilities; (e) Amgen had failed to comply with Accounting Standards Codification Topic 450 and other rules and regulations regarding the preparation of its periodic filings with the U.S. Securities and Exchange Commission; and (f) Amgen's refusal to pay taxes claimed by the U.S. government exposed the Company to a substantial risk of severe financial penalties imposed by the Internal Revenue Service.

United Natural Foods, Inc. (NYSE:UNFI)

UNFI Lawsuit on behalf of: investors who purchased March 10, 2021 - March 7, 2023
Lead Plaintiff Deadline : May 19, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/united-natural-foods-inc-lawsuit-submission-form?prid=38264&wire=1

According to the filed complaint, during the class period, United Natural Foods, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) despite its cost-saving Value Path initiative, United Natural Foods had not invested in improving its data management and related infrastructure; (2) as a result, the Company could not respond adequately to cost changes, such as inflationary pressure; (3) as a result, the Company could not appreciate the benefits of procurement gains and inventory gains achieved during fiscal 2022; (4) as a result of the foregoing, the Company's profitability would be materially adversely impacted; and (5) as a result of the foregoing, defendant's positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

GWG Holdings, Inc. (OTCMKT:GWGHQ)

GWGHQ Lawsuit on behalf of: investors who purchased December 23, 2017 - April 20, 2022
Lead Plaintiff Deadline : June 2, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/gwg-holdings-inc-information-request-form-2?prid=38264&wire=1

According to the filed complaint, during the class period, GWG Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Defendants intended to, and did, misappropriate GWG assets, (ii) GWG's life insurance investment business had failed, and (iii) GWG could only repay prior investors by issuing increasing amounts of securities to new investors. In essence, Defendants had turned GWG into a Ponzi scheme.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.